Insider trades
Thomas A. Fitzgerald, CEO of Transcode Therapeutics RNAZ, has filed 1 purchase and 0 sales on the open market. The latest trade was on 24/06/14.
Thomas A. Fitzgerald
Interim CEO, CFO
- Company
- Transcode Therapeutics RNAZ
- First filing
- 23/05/19
- Trades
- 3 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 24/06/14
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 23/09/28 | 23/10/02 | 49,350 sh | $0.51 | $25,168.5 | +708.2% |